期刊文献+

氨基末端-B型脑钠肽前体对急性呼吸困难鉴别诊断的临床观察 被引量:6

Clinical observation of N - terminal pro - brain natriuretic peptide in the differential diagnosis of acute dyspnea
下载PDF
导出
摘要 目的观察氨基末端-B型脑钠肽前体(NT—proBNP)在急性呼吸困难鉴别诊断中的临床意义。方法用电化学发光免疫法(ECLIA)测定186例急性呼吸困难患者血浆NT—proBNP浓度,包括心源性呼吸困难(A组)和肺源性呼吸困难(B组),观察两组血浆NT—proBNP浓度。结果血浆NT—proBNP浓度在A组明显高于B组,差异有统计学意义(P〈0.01);在A组,血浆NT—proBNP浓度与左室射血分数(LVEF)呈负相关(P〈0.01)。结论NT—proBNP在急性呼吸困难鉴别诊断中有重要的临床价值。 Objective To observe the clinical value of N - terminal pro - brain natriuretic peptide(NT -proBNP)in the differential diagnosis of acute dyspnea. Methods We determined plasma NT - proBNP concentration by electricity chemiluminescence immunoassay (ECLIA) in 186 patients with acute dyspnea, who were divided into two groups: cardiac dyspnea (group A)and pulmonary dyspnea (group B). The plasma NT- proBNP concentration were compared in group A and group B. Results The plasma NT - proBNP concentration was significantly higher in group A than in group B (P 〈0.01 );in group A, the plasma NT- proBNP concentration was negatively correlated with left ventricular ejection fraction (P 〈 0. 01 ). Conclusion The plasma NT - proBNP was helpful in the differential diagnosis of acute dyspnea.
出处 《中国急救医学》 CAS CSCD 北大核心 2012年第7期651-653,共3页 Chinese Journal of Critical Care Medicine
基金 贵州省科学技术基金资助项目(黔科合J字[2009]2206号)
关键词 急性呼吸困难 氨基末端-B型脑钠肽前体 心源性 肺源性 心力衰竭 Acute dyspnea N -terminal pro -brain natriuretic peptide (NT -proBNP) Cardiac dyspnea Pulmonary dyspnea Heart failure
  • 相关文献

参考文献16

  • 1Januzzi JL, Camargo CA, Anwaruddin S, et al. The N -terminal pro- BNP investigation of dyspnea in the emergency department (PRIDE)study[J]. Am J Cardiol, 2005, 95(8) : 948 -954.
  • 2Baggish AL, Siebert U, Lainchbury JG, et al. A validated clinical and biochemical score for the diagnosis of acute heart failure: the proBNP investigation of dyspnea in the emergency department (PRIDE)acute heart failure score[J]. Am Heart J, 2006, 151 48 - 54.
  • 3Maisel A. B -type natriuretic peptide levels: a potential novel "hite count" for congestive heart failure [ J]. J Cardiac Fail, 2001, 7(2) : 183 -193.
  • 4Morrison LK, Harrison A, Krishnaswamy P, et al. Utility of a rapid B - type natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea [J]. J Am Coil Cardiol, 2002, 39(2) : 202 -209.
  • 5Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurer ment of B - type natriuretic peptide in the emergency diagnosis of heart failure[J]. N Engl J Med, 2002, 347(3) : 161 -167.
  • 6Bayes - Genis A, Santalo - Bel M, Zapico - Muniz E, et al. N - terminal pro - brain natriuretic peptide ( NT - proBNP ) in the emergency diagnosis and inhospital monitoring of patients with dyspnoea and ventricular dysfunction [ J ]. Eur J Heart Fail, 2004, 6(3) : 301 -308.
  • 7ZileMR,GasschWH,CarrollJD,eta1.Heartfailurewithanor-malejectionfraction:ismeasurementofdiastolicfunctionnecessa-rytomakethediagnosisofdiastolicheartfailure[J].Circulation,2001,104(7):779-782.
  • 8Cleland JGF, Habib F. Assessment and diagnosis of heart failure [J]. Intern Med, 1996, 239:317 -325.
  • 9Wiese CH, Barrels UE, Graf BM, et al. Out - of - hospital opi- oid therapy of palliative care patient with acute dyspnoea: a retro- spective multicenter investigation [ J ]. J Opioid Manage, 2000, 5 (2) : 115 - 122.
  • 10李鹏,刘莹莹,张建军,佟子川,陈明,魏妤,缪国斌.氨基末端B型利钠肽前体和“急性呼吸困难”的诊断及预后[J].中华急诊医学杂志,2011,20(7):726-729. 被引量:8

二级参考文献12

  • 1贺正一.急诊症状处理——急性发作性呼吸困难[J].中国临床医生杂志,2005,33(3):50-52. 被引量:4
  • 2Wiese CH, Barrels UE, Graf BM, et al. Out-of-hospital opioid therapy of palliative care patients with acute dyspnoea: a retrospective multicenter investigation [ J ]. J Opioid Manag, 2000,5 (2): 115-122.
  • 3Januzzi JLJr, Camargo CA, Anwaruddin S, et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study [J]. Am J Cardiol, 2005, 95 (8) : 948-954.
  • 4Baggish AL, Siebert U, Lainchbury JG, et al. A validated clinical and biochemical score for the diagnosis of acute heart failure: the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Acute Heart Failure Score [J]. Am Heart J, 2006, 151 (1) : 48-54.
  • 5Januzzi JL, Van Kimmenade R , Lainehbury J , et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study [ J]. Eur Heart J, 2006, 27 (3): 330-337.
  • 6Berdague P, Caffin PY, Barazer I , et al . Use N-terminal prohormone brain natriuretie peptide assay for etiologic diagnosis of acute dyspnea in elderly patients [J]. Am Heart J, 2006, 151 (3) : 690-698.
  • 7Daniels LB, Maisel AS. Natriuretic peptides [ J]. J AM Coll Cardiol, 2007, 50 (25) : 2357-2368.
  • 8邵勉,姚晨玲,黄培志.氨基端前脑钠肽在不同年龄心力衰竭中的界值选择[J].中华急诊医学杂志,2008,17(5):479-482. 被引量:6
  • 9赵雪燕,杨跃进,张健,黄洁,倪新海,党爱民,康连鸣,康晟,毛懿,吴超,马卫华,赵冬云.B型利钠肽对心力衰竭患者心源性事件的预测价值[J].中国循环杂志,2008,23(4):263-266. 被引量:24
  • 10施国华,汪永锋,黄琪梁.N末端脑钠肽前体诊断心源性呼吸困难临床观察[J].疑难病杂志,2009,8(7):427-428. 被引量:10

共引文献68

同被引文献42

  • 1孙卫红.快速B型钠利尿肽检测与心力衰竭分级关系[J].中国生化药物杂志,2004,25(4):241-242. 被引量:6
  • 2李镛,顾学章.B-型利钠肽在肺科临床的应用[J].临床肺科杂志,2006,11(2):203-204. 被引量:24
  • 3陈灏珠.实用内科学[M].北京:人民卫生出版社,2009.
  • 4Tung R H, Camargo C A, Jr Krauser D, et al. Amino- terminal brain natriuretic peptide for the diagnosis of acute heart failure in patients with previous obstructive airway disease[J]. Ann Emerg Med, 2006, 48( 1 ) :66-74.
  • 5Baggish A L, van Kimmenade R R, Januzzi J L Jr. Ami- no-terminal pro-B-type natriuretic peptide testing and prognosis in patients with acute dyspnea, including those with acute heart failure [ J ]. Am J Cardiol, 2008, 101 (3A) :49-55.
  • 6Bayes-Genis A, DeFilippi C, Januzzi J L Jr. Understand- ing amino-terminal B-type natriuretic peptide in obesity [J]. Am J Cardiol, 2008, 101(3A) :89-94.
  • 7Lafaras C, Mandala E, Saratzis A, et al. Pro-brain natri- uretic peptide is a sensitive marker for detecting cardiac metastases in patients with non-small cell lung cancer [ J ]. Onkologie, 2009, 32 (7) :389-392.
  • 8Wu F, Wu Q. Corin-mediated processing of pro-atria/na- triuretic peptide in human small cell lung cancer cells [ J ]. Cancer Res, 2003, 63(23) :8318-8322.
  • 9Heikkila K, Ebrahim S, Lawlor D A. A systematic re- view of the association between circulating concentrations of C reactive protein and cancer [ J ]. J Epidemiol Com- munity Health, 2007, 61 (9) :824-833.
  • 10Tonstad S, Cowan J L. C-reactive protein as a predictor of disease in smokers and former smokers : a review [ J ]. Int J Clin Pract, 2009, 63( 11 ) :1634-1641.

引证文献6

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部